ZA962536B - Pharmaceutical composition for transdermal administration. - Google Patents
Pharmaceutical composition for transdermal administration.Info
- Publication number
- ZA962536B ZA962536B ZA9602536A ZA962536A ZA962536B ZA 962536 B ZA962536 B ZA 962536B ZA 9602536 A ZA9602536 A ZA 9602536A ZA 962536 A ZA962536 A ZA 962536A ZA 962536 B ZA962536 B ZA 962536B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical composition
- transdermal administration
- transdermal
- administration
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S602/00—Surgery: splint, brace, or bandage
- Y10S602/904—Film-forming bandage material
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9503776A FR2732223B1 (fr) | 1995-03-30 | 1995-03-30 | Composition pharmaceutique pour administration transdermique |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA962536B true ZA962536B (en) | 1997-09-29 |
Family
ID=9477595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9602536A ZA962536B (en) | 1995-03-30 | 1996-03-29 | Pharmaceutical composition for transdermal administration. |
Country Status (33)
Country | Link |
---|---|
US (1) | US6010716A (cs) |
EP (1) | EP0817621B2 (cs) |
JP (1) | JP3778937B2 (cs) |
KR (1) | KR100260237B1 (cs) |
CN (1) | CN1108790C (cs) |
AR (1) | AR001458A1 (cs) |
AT (1) | ATE202280T1 (cs) |
AU (1) | AU704150B2 (cs) |
BR (1) | BR9607862A (cs) |
CA (1) | CA2214845C (cs) |
CY (1) | CY2280B1 (cs) |
CZ (1) | CZ291914B6 (cs) |
DE (1) | DE69613463T3 (cs) |
DK (1) | DK0817621T4 (cs) |
EE (1) | EE9700241A (cs) |
ES (1) | ES2160239T5 (cs) |
FR (1) | FR2732223B1 (cs) |
GR (1) | GR3036630T3 (cs) |
HU (1) | HU227957B1 (cs) |
IL (1) | IL117728A (cs) |
IS (1) | IS2537B (cs) |
MX (1) | MX9707434A (cs) |
NO (1) | NO323583B1 (cs) |
NZ (1) | NZ305893A (cs) |
PL (1) | PL186004B1 (cs) |
PT (1) | PT817621E (cs) |
RU (1) | RU2161957C2 (cs) |
SI (1) | SI0817621T2 (cs) |
SK (1) | SK282634B6 (cs) |
TR (1) | TR199701083T1 (cs) |
TW (1) | TW442296B (cs) |
WO (1) | WO1996030000A1 (cs) |
ZA (1) | ZA962536B (cs) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6627216B2 (en) | 1998-08-20 | 2003-09-30 | 3M Innovative Properties Company | Spray on bandage and drug delivery system |
Families Citing this family (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4241706C2 (de) * | 1992-12-10 | 1997-03-20 | Ahlmann Aco Severin | Befestigungseinrichtung für die Abdeckung einer Oberflächenentwässerungseinrichtung |
AUPN814496A0 (en) | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
US6916486B2 (en) | 1996-02-19 | 2005-07-12 | Acrux Dds Pty Ltd | Transdermal delivery of analgesics |
US7094422B2 (en) | 1996-02-19 | 2006-08-22 | Acrux Dds Pty Ltd. | Topical delivery of antifungal agents |
US6998138B2 (en) | 1996-02-19 | 2006-02-14 | Acrux Dds Pty. Ltd. | Topical delivery of anti-alopecia agents |
US6916487B2 (en) | 1996-02-19 | 2005-07-12 | Acrux Dds Pty Ltd | Transdermal delivery of antiemetics |
US6923983B2 (en) | 1996-02-19 | 2005-08-02 | Acrux Dds Pty Ltd | Transdermal delivery of hormones |
US6929801B2 (en) | 1996-02-19 | 2005-08-16 | Acrux Dds Pty Ltd | Transdermal delivery of antiparkinson agents |
DE19616539A1 (de) * | 1996-04-25 | 1997-11-06 | Luitpold Pharma Gmbh | Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel |
US5955097A (en) * | 1996-10-18 | 1999-09-21 | Virotex Corporation | Pharmaceutical preparation applicable to mucosal surfaces and body tissues |
AUPO379596A0 (en) * | 1996-11-22 | 1996-12-19 | Soltec Research Pty Ltd | Percutaneous delivery system |
DE19742275A1 (de) * | 1997-09-25 | 1999-04-01 | Beiersdorf Ag | Estern verzweigtkettiger Carbonsäuren und verzweigtkettiger Alkohole als antibakterielle, antimycotische, antiparasitäre oder antivirale Wirkstoffe |
US6503488B1 (en) * | 1998-11-17 | 2003-01-07 | Tend Skin International, Inc. | Topical compositions including deodorant compositions |
FR2787712B1 (fr) * | 1998-12-24 | 2002-08-30 | Sanofi Sa | Composition cosmetique pulverisable et matrice utilisable dans cette composition pour une administration dermique |
NZ513208A (en) * | 1999-02-05 | 2003-05-30 | Cipla Ltd | Topical sprays comprising a film forming composition |
JP2003527310A (ja) * | 1999-04-16 | 2003-09-16 | イエナフアルム ゲーエムベーハー ウント ツェーオー. カーゲー | エストロゲンを局部的に皮内投与するための医薬品組成物または化粧品組成物 |
US6962691B1 (en) | 1999-05-20 | 2005-11-08 | U & I Pharmaceuticals Ltd. | Topical spray compositions |
AUPQ419099A0 (en) * | 1999-11-23 | 1999-12-16 | Ko, Thomas Sai Ying | Novel compositions and methods |
DE10019311A1 (de) * | 2000-04-19 | 2001-10-31 | Lohmann Therapie Syst Lts | Transdermale therapuetische Systeme zur Applikation von Moxonidin |
FR2808685B1 (fr) * | 2000-05-12 | 2004-10-08 | Sanofi Synthelabo | Compositions pharmaceutiques pour administration transdermique d'agents anti-inflammatoires |
DE10025971B4 (de) * | 2000-05-25 | 2004-09-02 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung |
DE10041478A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
US20040092494A9 (en) * | 2000-08-30 | 2004-05-13 | Dudley Robert E. | Method of increasing testosterone and related steroid concentrations in women |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
US20040002482A1 (en) * | 2000-08-30 | 2004-01-01 | Dudley Robert E. | Androgen pharmaceutical composition and method for treating depression |
US6479076B2 (en) * | 2001-01-12 | 2002-11-12 | Izhak Blank | Nicotine delivery compositions |
DE10107663B4 (de) * | 2001-02-19 | 2004-09-09 | Lts Lohmann Therapie-Systeme Ag | Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
US20030027793A1 (en) * | 2001-05-08 | 2003-02-06 | Thomas Lauterback | Transdermal treatment of parkinson's disease |
US20030026830A1 (en) * | 2001-05-08 | 2003-02-06 | Thomas Lauterback | Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
JP2004537516A (ja) * | 2001-05-11 | 2004-12-16 | オラセンス リミテッド | アンチセンス浸透促進剤 |
CA2449103A1 (en) * | 2001-06-01 | 2002-12-12 | Tendskin Company | Topical compositions for veterinary uses |
WO2003030823A2 (en) * | 2001-10-05 | 2003-04-17 | Combinatorx, Incorporated | Combinations for the treatment of immunoinflammatory disorders |
US20030118655A1 (en) * | 2001-12-21 | 2003-06-26 | Nikhil Kundel | Film forming liquid composition |
US20040048779A1 (en) * | 2002-05-06 | 2004-03-11 | Erwin Schollmayer | Use of rotigotine for treating the restless leg syndrome |
WO2004000263A1 (en) | 2002-06-25 | 2003-12-31 | Acrux Dds Pty Ltd | Transdermal delivery rate control using amorphous pharmaceutical compositions |
JPWO2004002452A1 (ja) * | 2002-06-27 | 2005-10-27 | ポーラ化成工業株式会社 | 医薬組成物 |
US9561182B2 (en) * | 2003-08-22 | 2017-02-07 | Cure Pharmaceutical Corporation | Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals |
US20040131662A1 (en) | 2003-11-12 | 2004-07-08 | Davidson Robert S. | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
US8999372B2 (en) * | 2002-11-14 | 2015-04-07 | Cure Pharmaceutical Corporation | Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use |
US20040191302A1 (en) * | 2003-03-28 | 2004-09-30 | Davidson Robert S. | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
DK1426049T3 (da) * | 2002-12-02 | 2005-08-22 | Sanol Arznei Schwarz Gmbh | Iontophoretisk tilförsel af rotigotin til behandling af Parkinsons sygdom |
JO2492B1 (en) | 2003-04-28 | 2009-10-05 | شيرينج ايه جي | A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients |
US20040265364A1 (en) * | 2003-06-25 | 2004-12-30 | Binnur Ozturk | Neuropathy cream |
US20050095277A1 (en) * | 2003-06-25 | 2005-05-05 | Binnur Ozturk | Neuropathy cream |
TW200517114A (en) * | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
MXPA06004460A (es) * | 2003-10-23 | 2006-06-27 | Cipla Ltd | Formulaciones en aerosol farmaceuticas transdermicas que comprenden un copolimero de vp/av y un vehiculo no acuoso. |
PL1750862T3 (pl) * | 2004-06-04 | 2011-06-30 | Teva Pharma | Kompozycja farmaceutyczna zawierająca irbesartan |
JP4705343B2 (ja) * | 2004-07-09 | 2011-06-22 | 日東電工株式会社 | 経皮吸収製剤用基剤およびこれを用いた皮膚貼付製剤 |
CN101027042B (zh) * | 2004-09-23 | 2012-07-25 | 陶氏环球技术公司 | 粘膜或皮肤的药物或卫生系统 |
US20070088012A1 (en) * | 2005-04-08 | 2007-04-19 | Woun Seo | Method of treating or preventing type-2 diabetes |
EP1877094A1 (en) * | 2005-05-03 | 2008-01-16 | Innozen, Inc. | Edible film for transmucosal delivery of nutritional supplements |
BRPI0611134A2 (pt) * | 2005-06-03 | 2010-08-17 | Acrux Dds Pty Ltd | método e composição para liberação transdérmica de fármaco |
PT1937276E (pt) | 2005-10-12 | 2013-02-21 | Besins Healthcare Luxembourg | Gel de testosterona melhorado e método para a sua utilização |
US20070258935A1 (en) * | 2006-05-08 | 2007-11-08 | Mcentire Edward Enns | Water dispersible films for delivery of active agents to the epidermis |
US20070259029A1 (en) * | 2006-05-08 | 2007-11-08 | Mcentire Edward Enns | Water-dispersible patch containing an active agent for dermal delivery |
CA2652773A1 (en) * | 2006-05-22 | 2007-12-06 | Combinatorx, Incorporated | Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels |
US20080057090A1 (en) * | 2006-09-01 | 2008-03-06 | Mcentire Edward Enns | Wrinkle masking film composition for skin |
US7879942B2 (en) * | 2006-10-05 | 2011-02-01 | Eastman Chemical Company | Switchable adhesive article for attachment to skin and method of using the same |
EP2106272A4 (en) | 2007-01-11 | 2011-05-04 | Acrux Dds Pty Ltd | SPREIZUTENSIL |
EP1987815A1 (en) * | 2007-05-04 | 2008-11-05 | Schwarz Pharma Ag | Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders |
CA2737131A1 (en) * | 2007-09-19 | 2009-03-26 | Zalicus Inc. | Therapeutic regimens for the treatment of immunoinflammatory disorders |
AU2008338980A1 (en) * | 2007-12-17 | 2009-06-25 | Zalicus Inc. | Therapeutic regimens for the treatment of immunoinflammatory disorders |
US10080760B2 (en) * | 2009-10-27 | 2018-09-25 | Besins Healthcare Luxembourg Sarl | Transdermal pharmaceutical compositions comprising active agents |
JP5966261B2 (ja) * | 2010-06-17 | 2016-08-10 | 大正製薬株式会社 | 外用組成物 |
CN102309447A (zh) * | 2010-07-06 | 2012-01-11 | 上海现代药物制剂工程研究中心有限公司 | 含盐酸奥昔布宁的自粘性喷雾透皮组合物及制备方法 |
US8481591B2 (en) | 2010-11-01 | 2013-07-09 | Stiefel Research Australia Pty. Ltd. | Polymeric topical compositions |
WO2013054809A1 (ja) * | 2011-10-14 | 2013-04-18 | 大正製薬株式会社 | 皮膚外用剤 |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
LT2782584T (lt) | 2011-11-23 | 2021-09-10 | Therapeuticsmd, Inc. | Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas |
JP2013147442A (ja) * | 2012-01-18 | 2013-08-01 | Kose Corp | グリチルレチン酸ステアリルの皮膚浸透促進剤 |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
RU2534521C2 (ru) * | 2012-11-27 | 2014-11-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Национальный исследовательский Томский государственный университет" (ТГУ) | Способ трансдермального введения инсулина и устройство для его осуществления |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
USD749225S1 (en) | 2013-11-26 | 2016-02-09 | Acrux Dds Pty Ltd | Topical spreading applicator |
USD750788S1 (en) | 2013-11-26 | 2016-03-01 | Acrux Dds Pty Ltd | Topical spreading applicator |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
KR20170040209A (ko) | 2014-07-29 | 2017-04-12 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 경피 크림 |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
DE102017104026A1 (de) * | 2017-02-27 | 2018-08-30 | Lts Lohmann Therapie-Systeme Ag | Nicotin enthaltendes transparentes transdermales therapeutisches System |
DE102017127433A1 (de) * | 2017-11-21 | 2019-05-23 | Lts Lohmann Therapie-Systeme Ag | TTS auf Basis von klebenden Weichmacher-Polymer-Matrices |
AU2019206552B2 (en) * | 2018-01-10 | 2023-02-09 | Celista Pharmaceuticals Llc | Testosterone transdermal spray with film |
CN109394735B (zh) * | 2018-11-09 | 2022-01-28 | 北京德默高科医药技术有限公司 | 具有高溶解度的布洛芬或其结构类似物经皮给药系统 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3045915A1 (de) * | 1980-12-05 | 1982-07-08 | Bayer Ag, 5090 Leverkusen | Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern |
DE3045914A1 (de) * | 1980-12-05 | 1982-07-22 | Bayer Ag, 5090 Leverkusen | Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern |
US4624665A (en) * | 1984-10-01 | 1986-11-25 | Biotek, Inc. | Method of transdermal drug delivery |
US4764381A (en) * | 1985-12-06 | 1988-08-16 | Key Pharmaceuticals, Inc. | Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol |
FR2612785A1 (fr) * | 1987-03-25 | 1988-09-30 | Lhd Lab Hygiene Dietetique | Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee |
EP0289900A1 (en) * | 1987-04-30 | 1988-11-09 | Abbott Laboratories | Topical antibacterial compositions |
JPH01503281A (ja) * | 1987-05-27 | 1989-11-09 | ブルグハルト,クルト | 経皮治療に有効な医薬包帯剤およびこれを施用するためのデバイス |
JPH07116035B2 (ja) * | 1987-12-08 | 1995-12-13 | 塩野義製薬株式会社 | 被膜形成性抗真菌剤組成物 |
FR2635979B1 (fr) * | 1988-09-07 | 1992-05-29 | Lhd Lab Hygiene Dietetique | Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee |
WO1994013257A1 (en) * | 1992-12-16 | 1994-06-23 | Creative Products Resource Associates, Ltd. | Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder |
US5547662A (en) * | 1993-08-27 | 1996-08-20 | Becton, Dickinson And Company | Preparation of a skin surface for a surgical procedure |
KR960011044B1 (ko) * | 1993-09-27 | 1996-08-16 | 재단법인 한국화학연구소 | 알칸올 투과가 우수한 고분자막 |
-
1995
- 1995-03-30 FR FR9503776A patent/FR2732223B1/fr not_active Expired - Fee Related
-
1996
- 1996-03-28 AR AR33595296A patent/AR001458A1/es active IP Right Grant
- 1996-03-29 CZ CZ19973081A patent/CZ291914B6/cs not_active IP Right Cessation
- 1996-03-29 PL PL96322502A patent/PL186004B1/pl unknown
- 1996-03-29 WO PCT/FR1996/000480 patent/WO1996030000A1/fr active IP Right Grant
- 1996-03-29 EP EP96911002A patent/EP0817621B2/fr not_active Expired - Lifetime
- 1996-03-29 SI SI9630331T patent/SI0817621T2/sl unknown
- 1996-03-29 DE DE69613463T patent/DE69613463T3/de not_active Expired - Lifetime
- 1996-03-29 TR TR97/01083T patent/TR199701083T1/xx unknown
- 1996-03-29 EE EE9700241A patent/EE9700241A/xx unknown
- 1996-03-29 MX MX9707434A patent/MX9707434A/es unknown
- 1996-03-29 DK DK96911002T patent/DK0817621T4/da active
- 1996-03-29 KR KR1019970707023A patent/KR100260237B1/ko not_active IP Right Cessation
- 1996-03-29 AT AT96911002T patent/ATE202280T1/de active
- 1996-03-29 ZA ZA9602536A patent/ZA962536B/xx unknown
- 1996-03-29 NZ NZ305893A patent/NZ305893A/xx not_active IP Right Cessation
- 1996-03-29 ES ES96911002T patent/ES2160239T5/es not_active Expired - Lifetime
- 1996-03-29 CA CA002214845A patent/CA2214845C/fr not_active Expired - Fee Related
- 1996-03-29 AU AU54022/96A patent/AU704150B2/en not_active Ceased
- 1996-03-29 BR BR9607862A patent/BR9607862A/pt not_active IP Right Cessation
- 1996-03-29 SK SK1306-97A patent/SK282634B6/sk not_active IP Right Cessation
- 1996-03-29 JP JP52902496A patent/JP3778937B2/ja not_active Expired - Fee Related
- 1996-03-29 PT PT96911002T patent/PT817621E/pt unknown
- 1996-03-29 HU HU9904174A patent/HU227957B1/hu not_active IP Right Cessation
- 1996-03-29 RU RU97118149/14A patent/RU2161957C2/ru not_active IP Right Cessation
- 1996-03-29 IL IL11772896A patent/IL117728A/xx not_active IP Right Cessation
- 1996-03-29 CN CN96193453A patent/CN1108790C/zh not_active Expired - Fee Related
- 1996-03-29 US US08/930,004 patent/US6010716A/en not_active Expired - Lifetime
- 1996-04-09 TW TW085104149A patent/TW442296B/zh not_active IP Right Cessation
-
1997
- 1997-09-22 IS IS4566A patent/IS2537B/is unknown
- 1997-09-29 NO NO19974507A patent/NO323583B1/no not_active IP Right Cessation
-
2001
- 2001-09-17 GR GR20010401488T patent/GR3036630T3/el unknown
-
2002
- 2002-05-15 CY CY0200034A patent/CY2280B1/xx unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6627216B2 (en) | 1998-08-20 | 2003-09-30 | 3M Innovative Properties Company | Spray on bandage and drug delivery system |
US6958154B2 (en) | 1998-08-20 | 2005-10-25 | 3M Innovative Properties Company | Spray on bandage and drug delivery system |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA962536B (en) | Pharmaceutical composition for transdermal administration. | |
ZA965190B (en) | Pharmaceutical composition. | |
AUPN605795A0 (en) | Analgesic pharmaceutical composition | |
ZA967034B (en) | Pharmaceutical compositions. | |
CY2359B1 (en) | Pharmaceutical formulation. | |
AU1689999A (en) | Medicinal composition for percutaneous administration | |
ZA968081B (en) | Pharmaceutical composition. | |
AU2345695A (en) | Pharmaceutical composition for transdermal delivery | |
ZA962214B (en) | Pharmaceutical composition | |
EP0683668A4 (en) | PREPARATIONS AND METHODS FOR TRANSDERMAL DRUG ADMINISTRATION. | |
ZA963590B (en) | Pharmaceutical composition | |
IL116912A0 (en) | Novel pharmaceutical combination for topical administration | |
AU7735798A (en) | Pharmaceutical composition for oral administration | |
ZA961051B (en) | Pharmaceutical composition | |
ZA9610426B (en) | Pharmaceutical composition | |
ZA964193B (en) | Pharmaceutical composition | |
ZA9610589B (en) | Pharmaceutical compounds. | |
ZA966083B (en) | Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one. | |
ZA963591B (en) | Pharmaceutical composition | |
HU9602822D0 (en) | Pharmaceutical composition | |
ZA95736B (en) | Pharmaceutical composition | |
AU1880599A (en) | Pharmaceutical composition for oral administration | |
AU6515496A (en) | Pharmaceutical administration form | |
IL112923A0 (en) | Pharmaceutical dosage form | |
GB9514807D0 (en) | Pharmaceutical composition |